The global cell dissociation market is on a robust growth trajectory, projected to expand from USD 352.91 million in 2023 to USD 1257.59 million by 2033, registering an impressive CAGR of 13.55% during the forecast period. This growth is fueled by heightened investments in research and development (R&D) within the pharmaceutical and healthcare industries.
Key Market Drivers:
The cell dissociation market is gaining momentum due to the critical role it plays in biopharmaceutical research, particularly in medicine creation and understanding pathophysiology. The biopharmaceutical sector, recognized for its exceptional safety and efficacy, has witnessed exponential growth, offering significant opportunities:
- Enhanced Medicines: Biopharmaceuticals enable targeted treatments with fewer side effects and the potential to address the root causes of diseases.
- Rising Investments: Increasing public and private funding is driving advancements in tissue dissociation enzymes, further boosting the market.
Market Restraints:
Despite its potential, the market faces certain challenges:
- High Costs: Expensive soft tissue operations could limit adoption.
- Preference Shift: The growing inclination towards enzyme-free dissociation products may impact enzymatic product demand.
Product Insights:
The market is segmented into:
- Enzymatic Dissociation Products (Dominant Segment): Includes enzymes like trypsin, collagenase, elastase, and hyaluronidase, widely used in stem cell research and single-cell harvesting.
- Non-Enzymatic Dissociation Products
- Instruments & Accessories
Enzymatic products continue to lead due to their widespread application in research and cell biology studies.
Regional Analysis:
- North America: Expected to dominate in 2023, driven by rising cancer and chronic illness rates, robust R&D investment trends, and industry collaborations.
- Asia Pacific: Poised for rapid growth due to government initiatives, increasing chronic disease prevalence, and the affordability of cell lysis and dissociation solutions.
- Europe: Forecasted to hold the second-largest revenue share, supported by well-established biotech and pharmaceutical industries.
The cell dissociation market is poised for substantial growth, supported by advancements in biopharmaceutical research, increasing chronic disease prevalence, and enhanced R&D investments. However, addressing cost barriers and product preferences will be critical to sustaining this momentum.
Growing Need for Market Insights: Access Our Full Report for Thorough Analysis and Trends!
Key Takeaways:
- The enzymatic dissociation category is likely to lead the market, accounting for almost 47.90% of sales in 2023
- From 2023 to 2033, the non-enzymatic segment in the cell dissociation industry is likely to expand at a significant CAGR.
- In 2023, the tissue dissociation type segment is dominant, accounting for 56.55% of the cell dissociation industry.
- Throughout the predicted period, the cell detachment type segment may blossom at a swift CAGR.
- In 2023, the pharmaceutical and biotechnology firms’ end-user segment is likely to dominate, accounting for 71.60% of the cell dissociation industry.
- North America is likely to lead the cell dissociation industry, accounting for 37.20% of the market in 2023.
- During the predicted period, Asia Pacific to exhibit a significant CAGR.
Economic Environment:
Leading cell dissociation manufacturers are investing in toxicity and efficacy investigations involving cell dissociation enzymes. This aspect is predicted to power substantial growth in the cell dissociation market during the forecast years.
To increase the industry footprint, cell dissociation manufacturers implement a variety of initiatives such as partnerships, mergers, acquisitions, and expansions.
Strategic Progressions for Cell Dissociation:
Acquisitions:
- December 8, 2021
PPD, Inc., a prominent provider of clinical research services, was acquired by Thermo Fisher Scientific Inc. The acquisition was valued at around US$ 17.4 billion and designed to boost Thermo Fisher Scientific’s position in the life sciences sector.
- April 9, 2020
Celsee, Inc., a leading manufacturer of single-cell analysis equipment, was acquired by Bio-Rad Laboratories, Inc. The acquisition sought to broaden Bio-Rad Laboratories’ product offerings in the single-cell analysis industry.
- June 1, 2020
Becton, Dickinson, and Company purchased Straub Medical AG, a leading provider of medical equipment for the diagnosis and treatment of venous disorders. The acquisition sought to broaden Becton, Dickinson and Company’s product portfolio in the vascular access market.
Key Players:
- HiMedia Laboratories
- F. Hoffmann-La Roche Ltd.
- Merck KGaA
- Thermo Fisher Scientific
- Sartorius AG
- S2 Genomics, Inc.
- Danaher Corp.
- STEMCELL Technologies
- BD
- Miltenyi Biotec
- PAN-Biotech
Key Segments:
Cell Dissociation Industry by Product:
- Enzymatic dissociation
- Non-enzymatic dissociation
- Instruments & Accessories
Cell Dissociation Industry by Type:
- Cell dissociation for Tissue Dissociation
- Cell dissociation for Cell Detachment
Cell Dissociation Industry by End User:
- Cell dissociation for Pharmaceutical and Biotechnology Companies
- Cell dissociation for Research and Academic Institutes
Cell Dissociation Industry by Region:
- Cell dissociation in North America Market
- Cell dissociation in Latin America Market
- Cell dissociation in Europe Market
- Cell dissociation in East Asia Market
- Cell dissociation in South Asia and Pacific Market
- Cell dissociation in The Middle East and Africa (MEA) Market
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
